Advertisement

Topics

CR UK trials early-stage Lilly drug

07:16 EDT 23 Aug 2017 | PharmaTimes

Cancer Research UK has launched a new multi-site trial of an early-stage experimental therapy owned by Eli Lilly assessing its potential in a range of advanced cancers.

Original Article: CR UK trials early-stage Lilly drug

NEXT ARTICLE

More From BioPortfolio on "CR UK trials early-stage Lilly drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...